Spring Pharmaceutical (CYIG) 10-Q 2010 Q2 Quarterly report

EXHIBIT 32: Rule 13a-14(b) Certification

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officers of China YCT International Group, Inc. (the “Company”) certifies that:

1.           The Quarterly Report on Form 10-Q of the Company for the quarter ended September 30, 2009 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

2.           The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

November 16, 2009   /s/ Yan Tinghe

     Yan Tinghe, Chief Executive Officer

November 16, 2009    /s/ Zhang Jirui

     Zhang Jirui, Chief Financial Officer